Elizabeth Gibb, MD

Title(s)Associate Professor, Pediatrics
SchoolSchool of Medicine
Address2401 Shadelands Drive, #4772
Walnut Creek CA
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Yale, New Haven, CTB.S.2002Molecular, Cellular and Developmental Biology
    University of Cambridge, Cambridge, UKM. Phil2003Biochemistry
    Harvard, Boston, MAMD2007
    University of California, San Francisco, SF, CA2010Pediatric Residency
    University of California, San Francisco, SF, CA2013Pediatric Pulmonary Fellowship

    Collapse Overview 
    Collapse Overview
    Dr. Elizabeth Gibb cares for children with complicated medical conditions and their families, with a commitment to managing their care both over time and during severe episodes. She specializes in treating asthma, bronchopulmonary dysplasia, interstitial lung disease, cystic fibrosis, primary ciliary dyskinesia, sleep apnea and respiratory conditions related to neuromuscular disease, as well as in performing flexible bronchoscopy and pulmonary function tests. Her research focuses on Cystic Fibrosis treatments.

    Dr. Gibb earned a master of philosophy degree in biochemistry at the University of Cambridge and her medical degree from Harvard Medical School. She completed a residency in pediatrics and a fellowship in pediatric pulmonary medicine at UCSF. She is a member of the American Academy of Pediatrics. She wrote, produced and directed a UCSF teaching video on pediatric asthma.

    Collapse Featured Content 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Time to be blunt: Substance use in cystic fibrosis. Pediatr Pulmonol. 2024 Apr; 59(4):1015-1027. Vaziri S, McGarry ME, Huang CY, Cuneo AA, Willen SM, Iwanaga K, Neemuchwala F, Gibb ER, Chan M, Ly NP. PMID: 38251844.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Cystic fibrosis transmembrane conductance regulator modulator administration to a F508del heterozygous infant with meconium pseudocyst and short bowel syndrome: A case report. Pediatr Pulmonol. 2024 Mar; 59(3):791-793. Stoffella S, Ly N, McGarry M, Neemuchwala F, Church G, Chan M, Cuneo A, Omori M, Gibb E. PMID: 38088240.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. How many billions is enough? Prioritizing profits over patients with cystic fibrosis. Pediatr Pulmonol. 2023 05; 58(5):1595-1597. McGarry ME, Gibb ER, Laguna TA, O'Sullivan BP, Sawicki GS, Zobell JT. PMID: 36722731; PMCID: PMC10121825.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    4. Food insecurity and mental health during the COVID-19 pandemic in cystic fibrosis households. Pediatr Pulmonol. 2022 05; 57(5):1238-1244. Lim JT, Ly NP, Willen SM, Iwanaga K, Gibb ER, Chan M, Church GD, Neemuchwala F, McGarry ME. PMID: 35112507.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    5. Left behind: The potential impact of CFTR modulators on racial and ethnic disparities in cystic fibrosis. Paediatr Respir Rev. 2022 Jun; 42:35-42. McGarry ME, Gibb ER, Oates GR, Schechter MS. PMID: 35277357; PMCID: PMC9356388.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    6. Patient and Provider Experience With Cystic Fibrosis Telemedicine Clinic. Front Pediatr. 2021; 9:784692. Hendra K, Neemuchwala F, Chan M, Ly NP, Gibb ER. PMID: 34900879; PMCID: PMC8653948.
      View in: PubMed   Mentions: 2  
    7. Functional Profiling of CFTR-Directed Therapeutics Using Pediatric Patient-Derived Nasal Epithelial Cell Models. Front Pediatr. 2020; 8:536. Park JK, Shrivastava A, Zhang C, Pollok BA, Finkbeiner WE, Gibb ER, Ly NP, Illek B. PMID: 33014932; PMCID: PMC7500161.
      View in: PubMed   Mentions: 9  
    8. Asthma, FEF25-75, and Hospitalizations in Children. Pediatr Allergy Immunol Pulmonol. 2013 Sep; 26(3):115-121. Gibb ER, Thyne SM, Kaplan DN, Ly NP. PMID: 35923031.
      View in: PubMed   Mentions: 1     Fields:    
    9. Management of plastic bronchitis with topical tissue-type plasminogen activator. Pediatrics. 2012 Aug; 130(2):e446-50. Gibb E, Blount R, Lewis N, Nielson D, Church G, Jones K, Ly N. PMID: 22802609.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    Elizabeth's Networks
    Concepts (34)
    Derived automatically from this person's publications.
    Co-Authors (15)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department